Updated Jul 16, 2026
Robinson Chandler has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $672K.
Robinson Chandler is the Chief Executive Officer of Monopar Therapeutics, a biopharmaceutical company focused on developing innovative therapies for cancer treatment. His leadership role involves overseeing the company's strategic direction and operations.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | MNPR | Monopar Therapeutics | F — Tax withholding / forfeiture | 4.1K | $92.59 | $378K |
| 2026-07-02 | MNPR | Monopar Therapeutics | M — Option exercise | 12.9K | — | |
| 2026-04-02 | MNPR | Monopar Therapeutics | F — Tax withholding / forfeiture | 2.0K | $54.79 | $108K |
| 2026-04-02 | MNPR | Monopar Therapeutics | M — Option exercise | 6.7K | — | |
| 2026-01-30 | MNPR | Monopar Therapeutics | J — Other acquisition / disposition | 62.8K | $0.00 | |
| 2025-09-30 | MNPR | Monopar Therapeutics | F — Tax withholding / forfeiture | 2.6K | $81.67 | $216K |
| 2025-09-30 | MNPR | Monopar Therapeutics | M — Option exercise | 8.7K | — | |
| 2025-07-14 | MNPR | Monopar Therapeutics | S — Open-market sale | 16.8K | $40.00 | $672K |
| 2025-07-14 | MNPR | Monopar Therapeutics | J — Other acquisition / disposition | 16.8K | $0.01 | $84 |
| 2025-06-30 | MNPR | Monopar Therapeutics | F — Tax withholding / forfeiture | 5.9K | $35.78 | $210K |
| 2025-06-30 | MNPR | Monopar Therapeutics | M — Option exercise | 13.3K | — | |
| 2024-10-02 | MNPR | Monopar Therapeutics | F — Tax withholding / forfeiture | 1.9K | $6.74 | $13K |
| 2024-10-02 | MNPR | Monopar Therapeutics | M — Option exercise | 4.9K | — |
Robinson Chandler is the Chief Executive Officer of Monopar Therapeutics, a biopharmaceutical company focused on developing innovative therapies for cancer treatment. His leadership role involves overseeing the company's strategic direction and operations.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($672K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Robinson Chandler profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.